中医药治疗风湿免疫领域临床优势病种的探讨

Expert Consensus on Rheumatic Immune Diseases Responding Specifically to Traditional Chinese Medicine

中医药治疗风湿免疫疾病的优势病种、中西医结合切入点仍不明确,制订中医、西医普遍认可、融合的诊疗方案是亟待解决的问题。为明确中医、中西医结合风湿病优势病种和优势环节,由中华中医药学会发起风湿领域中医优势病种青年沙龙研讨会(以下简称风湿优势病种青年沙龙),以广泛涵盖中医、西医风湿领域专家的研讨小组为主体,采用问卷调查和现场研讨两种形式,充分探讨中医药治疗风湿免疫疾病的优势,明确中西医结合切入点,初步形成一致意见,为制订出中医西医普遍认可、融合的诊疗方案提供基础。风湿优势病种青年沙龙与会专家一致认为,应结合现代医学方法、现代科技手段开展循证医学研究,为践行“宜中则中、宜西则西”的指导思想提供客观临床证据;要以“四个互”为要求,即语境互通、学理互释、标准互证、手段互融,要着重解决难治性风湿病;在优势病种和优势点上,本文介绍达成广泛共识的类风湿关节炎、强直性脊柱炎、干燥综合征、高尿酸血症与痛风、系统性红斑狼疮、纤维肌痛综合征等6种优势疾病的21个优势环节。本研究为风湿病中医、中西医结合诊疗方案提供参考,为临床实际诊疗和科学研究提供参考依据和有益借鉴。

In the clinical practice of rheumatic immune diseases in traditional Chinese medicine(TCM),it`s still unclear about the dominant diseases and breakthrough points.It`s urgent missions to formulate TCM diagnosis and treatment guidelines widely recognized and integrated by traditional Chinese medicine and Western medicine.In order to clarify the dominant diseases and breakthrough points in rheumatism,China association of Chinese medicine initiated a research group covering experts in the field of rheumatism of traditional Chinese medicine and Western medicine.Based on questionnaire survey and on-site discussion,experts had reached the following consensus.Evidence-based medicine research using modern medical methods and scientific methods should be carried out to provide objective clinical evidences."Four mutuality"were put forward as the basis for the work of integrated traditional Chinese and Western medicine,that is the mutual communication using the exchangeable context,the mutual explanation using common theories,the mutual certification using common standards,and the mutual integration using common means.Key works should focus on solving refractory rheumatism in the future.In terms of dominant diseases and breakthrough points,this paper introduces21 breakthrough points in 6 dominant diseases,including rheumatoid arthritis,ankylosing spondylitis,Sjogren’s syndrome,hyperuricemia and gout,systemic lupus erythematosus and fibromyalgia syndrome.Advice on this discussion can provide valuable references for developing the treatment scheme of rheumatism with TCM and integrated Chinese and Western medicine and clinical practice and scientific research.